NeoGenomics (NEO) Tops Q2 EPS by 6c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $146.92 million versus the consensus estimate of $137.42 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Veeva Systems (VEEV) Tops Q1 EPS by 10c, Offers Guidance
• Jefferies, UBS downgrade Victoria's Secret as rally leaves limited upside